Gervasoni C - Search Results

1

Does lopinavir really inhibit SARS-CoV-2?

Cattaneo D, Cattaneo D, Gervasoni C, Corbellino M, Galli M, Riva A, Gervasoni C, Clementi E, Clementi E. Cattaneo D, et al. Among authors: gervasoni c. Pharmacol Res. 2020 Aug;158:104898. doi: 10.1016/j.phrs.2020.104898. Epub 2020 May 11. Pharmacol Res. 2020. PMID: 32438034 Free PMC article.

2

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy.

Gervasoni C, Ridolfo AL, Trifirò G, Santambrogio S, Norbiato G, Musicco M, Clerici M, Galli M, Moroni M. Gervasoni C, et al. AIDS. 1999 Mar 11;13(4):465-71. doi: 10.1097/00002030-199903110-00004. AIDS. 1999. PMID: 10197374

3

Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum.

Ridolfo AL, Gervasoni C, Antinori S, Pizzuto M, Santambrogio S, Trabattoni D, Clerici M, Galli M. Ridolfo AL, et al. Among authors: gervasoni c. J Infect. 2000 Mar;40(2):199-202. doi: 10.1053/jinf.1999.0630. J Infect. 2000. PMID: 10841104

4

Body habitus alterations in HIV-infected women treated with combined antiretroviral therapy.

Ridolfo AL, Gervasoni C, Bini T, Galli M. Ridolfo AL, et al. Among authors: gervasoni c. AIDS Patient Care STDS. 2000 Nov;14(11):595-601. doi: 10.1089/10872910050193770. AIDS Patient Care STDS. 2000. PMID: 11155901

5

Fat redistribution in HIV-infected patients. A new hormonal-immune disorder?

Norbiato G, Trifirò G, Galli M, Gervasoni C, Clerici M. Norbiato G, et al. Among authors: gervasoni c. Ann N Y Acad Sci. 2000;917:951-5. doi: 10.1111/j.1749-6632.2000.tb05461.x. Ann N Y Acad Sci. 2000. PMID: 11268426

6

Cardiovascular disease risk factors in HIV-infected patients in the HAART era.

Galli M, Ridolfo AL, Gervasoni C. Galli M, et al. Among authors: gervasoni c. Ann N Y Acad Sci. 2001 Nov;946:200-13. doi: 10.1111/j.1749-6632.2001.tb03913.x. Ann N Y Acad Sci. 2001. PMID: 11762987 Review.

7

Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors.

Galli M, Ridolfo AL, Adorni F, Gervasoni C, Ravasio L, Corsico L, Gianelli E, Piazza M, Vaccarezza M, d'Arminio Monforte A, Moroni M. Galli M, et al. Among authors: gervasoni c. J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):21-31. doi: 10.1097/00126334-200201010-00003. J Acquir Immune Defic Syndr. 2002. PMID: 11782586

8

Maintenance of breast size reduction after mastoplasty and switch to a protease inhibitor-sparing regimen in an HIV-positive woman with highly active antiretroviral therapy-associated massive breast enlargement.

Gervasoni C, Ridolfo AL, Rovati L, Vaccarezza M, Carsana L, Galli M. Gervasoni C, et al. AIDS Patient Care STDS. 2002 Jul;16(7):307-11. doi: 10.1089/108729102320231135. AIDS Patient Care STDS. 2002. PMID: 12194727

9

Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy.

Gervasoni C, Ridolfo AL, Vaccarezza M, Parravicini C, Vago L, Adorni F, Cappelletti A, d'Arminio Monforte A, Galli M. Gervasoni C, et al. Clin Infect Dis. 2002 Dec 15;35(12):1534-40. doi: 10.1086/344778. Epub 2002 Dec 2. Clin Infect Dis. 2002. PMID: 12471574

10

Cytokine production in women with antiretroviral treatment-associated breast fat accumulation and limb wasting.

Galli M, Gervasoni C, Ridolfo AL, Trabattoni D, Santambrogio S, Vaccarezza M, Meroni L, Trifirò G, Moroni M, Norbiato G, Clerici M. Galli M, et al. Among authors: gervasoni c. AIDS. 2003 Apr;17 Suppl 1:S155-61. doi: 10.1097/00002030-200304001-00019. AIDS. 2003. PMID: 12870542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page